Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Neoplasms 6Pancreatic Neoplasms 3Pancreatic Cyst 2Wilms Tumor 1Uveal Melanoma 1Thyroid Nodule 1Thyroid Diseases 1Prostatic Neoplasms 1Peutz-Jeghers Syndrome 1Pancreatitis, Chronic 1Ovarian Neoplasms 1Neuroendocrine Tumors 1Neoplasm Metastasis 1Myasthenia Gravis 1Mesothelioma, Malignant 1Mesothelioma 1Lymphoma, Non-Hodgkin 1Lymphoma 1Lung Neoplasms 1Leukemia 1Intestinal Neuroendocrine Tumor 1Hyperthyroidism 1Hip Fractures 1Hematologic Neoplasms 1Goiter 1Glioma 1Glioblastoma 1Frailty 1Fractures, Spontaneous 1Financial Stress 1

Interventions

Cyclophosphamide 3regorafenib 2Proton Therapy 2Methods 2Gemcitabine 2Doxorubicin 2tocilizumab 1poly ICLC 1pembrolizumab 1liposomal doxorubicin 1fludarabine 1flt3 ligand protein 1endostar protein 1alectinib 1aldesleukin 1Weight-Bearing 1Transcranial Direct Current Stimulation 1Taxes 1Surveys and Questionnaires 1Standard of Care 1Restraint, Physical 1Range of Motion, Articular 1Radiotherapy 1Radiosurgery 1Radiation 1Quality of Life 1Psychology, Positive 1Platinum 1Paclitaxel 1Observation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Bone Neoplasms × Data Collection × 1 year × Clear all
NCT07215611 2026-04-30

Financial Toxicity in Patients With Resected Soft Tissue and Bone Sarcomas

M.D. Anderson Cancer Center

Recruiting
100 enrolled
Sarcoma

Financial Stress, Bone Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡